Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
US7687075 | SALIX PHARMS | Colonic purgative composition with soluble binding agent |
Jun, 2028
(5 years from now) |
Market Authorisation Date: 16 March, 2006
Treatment: NA
Dosage: TABLET;ORAL
5
Australia
5
United States
4
Korea, Republic of
3
Japan
2
Canada
2
Brazil
2
China
2
European Union
1
Argentina
1
Spain
1
Poland
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic